Norges Bank’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-28,900
Closed -$257K 1965
2024
Q2
$257K Sell
28,900
-95,400
-77% -$915K ﹤0.01% 1910
2024
Q1
$1.26M Buy
124,300
+92,387
+289% +$941K ﹤0.01% 1777
2023
Q4
$321K Sell
31,913
-1,057,624
-97% -$9.66M ﹤0.01% 1916
2023
Q3
$10.2M Buy
1,089,537
+312,387
+40% +$4.46M ﹤0.01% 1467
2023
Q2
$19.1M Buy
777,150
+140,200
+22% +$3.52M ﹤0.01% 1276
2023
Q1
$14.8M Sell
636,950
-91,610
-13% -$2.34M ﹤0.01% 1414
2022
Q4
$18.4M Buy
728,560
+112,693
+18% +$2.76M ﹤0.01% 1309
2022
Q3
$11.9M Buy
615,867
+17,503
+3% +$445K ﹤0.01% 1464
2022
Q2
$15.2M Buy
598,364
+45,247
+8% +$1.06M ﹤0.01% 1374
2022
Q1
$14.2M Buy
553,117
+55,697
+11% +$1.65M ﹤0.01% 1561
2021
Q4
$20.8M Buy
497,420
+103,751
+26% +$4.06M ﹤0.01% 1454
2021
Q3
$17.1M Buy
393,669
+101,994
+35% +$4.42M ﹤0.01% 1573
2021
Q2
$13.8M Sell
291,675
-213,852
-42% -$9.72M ﹤0.01% 1684
2021
Q1
$25.9M Sell
505,527
-65,717
-12% -$3.54M 0.01% 1377
2020
Q4
$15.3M Sell
571,244
-68,094
-11% -$2.21M ﹤0.01% 1647
2020
Q3
$21.9M Sell
639,338
-173,578
-21% -$7.47M 0.01% 1363
2020
Q2
$33.3M Buy
+812,916
New +$27.3M 0.01% 1122
2020
Q1
Sell
-25,000
Closed -$314K 2074
2019
Q4
$314K Buy
+25,000
New +$335K ﹤0.01% 2067

Other funds holding VIR